Pharmacy and the U.S. Health Care System, Third EditionCRC Press, 2005 M07 22 - 476 pages The healthcare field is rapidly evolving, compelled by technological strides, pressure to increase efficiency, and demand to contain costs. Pharmacy and the U.S. Health Care System, Third Edition is the classic text used to prepare pharmacists for independent practice in today's unpredictable environment since the first edition was published in 1991. This new edition is now streamlined and tailored for a one-semester course, completely updated with the most recent data, statistics, and emerging issues relevant to today's pharmacy professional, with new chapters devoted to the political realities of the industry and the future of pharmacy. |
From inside the book
Results 1-5 of 88
Page viii
... Role of Pharmacy Organizations 113 Historical Development of Pharmacy Organizations 117 Specific Pharmacy ... Roles 133 Richard J. Bertin Introduction 133 Advanced Practice Credentialing 134 Collaborative Drug Therapy Management 141 ...
... Role of Pharmacy Organizations 113 Historical Development of Pharmacy Organizations 117 Specific Pharmacy ... Roles 133 Richard J. Bertin Introduction 133 Advanced Practice Credentialing 134 Collaborative Drug Therapy Management 141 ...
Page ix
... Role of Pharmacists 161 The Next Political Reality : Genetics 163 Looking Ahead 163 Chapter 9. Hospital and Health Care Institutions 169 Types of Hospitals Health Care Staffing Hospital Ownership Regulation Charles E. Daniels ...
... Role of Pharmacists 161 The Next Political Reality : Genetics 163 Looking Ahead 163 Chapter 9. Hospital and Health Care Institutions 169 Types of Hospitals Health Care Staffing Hospital Ownership Regulation Charles E. Daniels ...
Page x
Michael Smith. Long - Term Care 201 Nursing Facilities 203 The Role of the Geriatric Pharmacist in Other Senior Settings 210 Future Payer Initiatives 217 Conclusion 218 Chapter 11. The Pharmaceutical Research Manufacturing Industry 227 ...
Michael Smith. Long - Term Care 201 Nursing Facilities 203 The Role of the Geriatric Pharmacist in Other Senior Settings 210 Future Payer Initiatives 217 Conclusion 218 Chapter 11. The Pharmaceutical Research Manufacturing Industry 227 ...
Page 5
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 6
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Contents
V | 1 |
VI | 6 |
VII | 9 |
VIII | 12 |
IX | 17 |
X | 18 |
XI | 21 |
XII | 23 |
LXXVI | 210 |
LXXVII | 217 |
LXXVIII | 218 |
LXXIX | 227 |
LXXX | 229 |
LXXXI | 232 |
LXXXII | 233 |
LXXXIII | 235 |
XIII | 29 |
XIV | 35 |
XV | 41 |
XVI | 43 |
XVII | 44 |
XVIII | 46 |
XIX | 49 |
XX | 54 |
XXI | 58 |
XXII | 61 |
XXIII | 62 |
XXIV | 65 |
XXV | 68 |
XXVI | 74 |
XXVIII | 76 |
XXIX | 78 |
XXX | 81 |
XXXI | 84 |
XXXII | 88 |
XXXIII | 92 |
XXXIV | 93 |
XXXV | 94 |
XXXVI | 108 |
XXXVII | 113 |
XXXIX | 117 |
XL | 118 |
XLI | 129 |
XLII | 130 |
XLIII | 133 |
XLIV | 134 |
XLV | 141 |
XLVI | 143 |
XLVII | 145 |
XLVIII | 147 |
XLIX | 148 |
L | 149 |
LI | 150 |
LII | 153 |
LIII | 155 |
LV | 158 |
LVI | 160 |
LVII | 161 |
LVIII | 163 |
LX | 169 |
LXI | 171 |
LXII | 173 |
LXIII | 174 |
LXIV | 178 |
LXV | 180 |
LXVI | 184 |
LXVII | 186 |
LXVIII | 187 |
LXIX | 188 |
LXX | 189 |
LXXI | 193 |
LXXII | 196 |
LXXIII | 197 |
LXXIV | 201 |
LXXV | 203 |
LXXXIV | 236 |
LXXXV | 237 |
LXXXVI | 239 |
LXXXVII | 240 |
LXXXVIII | 241 |
LXXXIX | 243 |
XC | 244 |
XCI | 246 |
XCII | 247 |
XCIII | 248 |
XCIV | 249 |
XCV | 253 |
XCVI | 254 |
XCVII | 255 |
XCVIII | 258 |
XCIX | 260 |
C | 264 |
CI | 275 |
CII | 283 |
CIII | 290 |
CIV | 297 |
CV | 298 |
CVI | 299 |
CVII | 300 |
CVIII | 313 |
CIX | 316 |
CX | 325 |
CXI | 326 |
CXII | 344 |
CXIV | 345 |
CXVI | 346 |
CXVII | 351 |
CXVIII | 353 |
CXIX | 357 |
CXXI | 358 |
CXXII | 364 |
CXXIII | 374 |
CXXIV | 376 |
CXXV | 380 |
CXXVI | 385 |
CXXVII | 389 |
CXXVIII | 403 |
CXXIX | 404 |
CXXX | 405 |
CXXXI | 406 |
CXXXII | 408 |
CXXXIII | 409 |
CXXXIV | 411 |
CXXXV | 412 |
CXXXVI | 414 |
CXXXVII | 415 |
CXXXVIII | 417 |
CXL | 418 |
CXLI | 423 |
CXLII | 430 |
CXLIII | 439 |
445 | |
Other editions - View all
Common terms and phrases
activities Administration American antibodies Available online behavior benefit Biotechnology Biotechnology Industry Organization cells Center changes chronic cists clinical pharmacy Colleges of Pharmacy community pharmacy consultant pharmacist consumers cost coverage cultural cytokines decision diffusion of innovations disease dispensing drug therapy effects elderly employees factors federal gene gene therapy genetic genomics geriatric health care providers health care system health insurance health professions health services Health-System Hispanic HMOs hospital Ibid increase individual industry innovations interactions interferons issues Journal macists macy managed managed care manufacturers Medicaid Medicare medications Medicine monoclonal antibodies National noncompliance nursing home outcomes PBMs percent phar pharma Pharmaceutical Association Pharmacogenetics pharmacy organizations pharmacy practice pharmacy services physician plans population practitioners prescribing prescription drugs problems professional programs protein reimbursement response role social technicians therapeutic tion treatment U.S. Census Bureau U.S. Department U.S. health United utilization vaccines workforce